← Eichor
Condition: Pediatric Hematopoietic Stem Cell Transplantation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pediatric Hematopoietic Stem Cell Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Massage Impact on Sleep in Pediatric Oncology
NA · 2 location(s) · Children's Hospital of Philadelphia · NCT06892158A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Lif
Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT05029531Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Ste
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT07662018A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Phase 3 · 81 location(s) · SymBio Pharmaceuticals · NCT07387367Multi-omic Characterization of Pediatric and Adult Patients Undergoing Hematopoietic Stem Cell Transplantation and Advan
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07464483Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hemat
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05011422The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
NA · 1 location(s) · Nationwide Children's Hospital · NCT07718204A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditionin
Phase 2 · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06564493Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Pati
NA · 2 location(s) · M.D. Anderson Cancer Center · NCT04678427Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Phase N/A · 5 location(s) · MSD Italia S.r.l. · NCT06916195CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transp
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT07257419Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Al
Phase 1/Phase 2 · 1 location(s) · Smart Immune SAS · NCT04959903Design and Implementation of the Pediatric Liver Transplantation Biobank
Phase N/A · 1 location(s) · Children's Hospital of Chongqing Medical University · NCT04477967Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
Phase N/A · 10 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06861257HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
NA · 2 location(s) · University of California, San Francisco · NCT06386198Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation
NA · 1 location(s) · Alejandro Lucia · NCT06300515Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
NA · 1 location(s) · Hong Kong Children's Hospital · NCT06075563Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic
Phase 2 · 1 location(s) · Seoul National University Hospital · NCT06247501Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumor
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT02508038Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell
Phase 2 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07256210Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · 71 location(s) · New York Blood Center · NCT01656603Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Condition
Phase 2 · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06559345Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Hos
Phase 4 · 22 location(s) · Novartis Pharmaceuticals · NCT06824103A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstructio
Phase N/A · 3 location(s) · Duke University · NCT05090345T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Phase 1/Phase 2 · 1 location(s) · Paul Szabolcs · NCT03653338Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cel
NA · 1 location(s) · Peking University People's Hospital · NCT06581081Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infe
NA · 1 location(s) · LucasBio · NCT07685457Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Phase 3 · 17 location(s) · Vastra Gotaland Region · NCT05477589
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.